Skip to content
Screener
Xtant Medical Holdings logo

Xtant Medical Holdings

XTNT

Xtant Medical Holdings, Inc. is a global medical technology company that designs, develops, and commercializes a comprehensive portfolio of orthobiologics and spinal implant fixation systems.

Market cap
$44.89M-50.7%
Revenue$109.5M-14.3%
Net income-$11.1M-143%
Free cash flow-$696.0K+75.4%
EPS (diluted)-$0.08-100%
Trailing twelve months · change vs. prior year

Earnings

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$25.5M
EPS estimate-$0.03

Financials

Q2 2026

Income statement

See full
Revenue$23.0M-35.0%
Gross profit$13.3M-45.1%
Operating income-$9.2M-298%
Net income-$9.4M-365%
EPS (diluted)-$0.07-450%

Balance sheet

See full
Cash & equivalents$10.2M+45.2%
Total debt$14.0M-44.0%
Total equity$40.0M-17.5%
Total assets$79.7M-23.0%

Cash flow

See full
Operating cash flow-$7.3M-673%
CapEx$247.0K-32.5%
Free cash flow-$7.6M-930%

Valuation & ratios

Valuation

See full
Market cap$44.89M-50.7%
Enterprise value$48.7M-52.5%
P/S0.4×-0.3×

Profitability

See full
Gross margin59.4%-0.8pp
Net margin-10.2%-22.3pp
FCF margin-0.6%-0.3pp

Returns & leverage

See full
Return on equity-25.2%-69.5pp
Debt / equity0.4×-0.2×
Current ratio2.2×-0.3×

Segments

By product

See full
Orthobiologics$17.4M-10.4%
Spinal Implant$5.7M-48.8%

Competitors

Profile

Xtant Medical Holdings, Inc. is a global medical technology company that designs, develops, and commercializes a comprehensive portfolio of orthobiologics and spinal implant fixation systems. The company's solutions facilitate spinal fusion in complex spine, deformity, and degenerative procedures, while its biologics are also utilized in trauma, sports medicine, and wound care. Xtant's core value proposition lies in providing a dual-portfolio approach that combines human-derived tissue products with advanced hardware systems to improve surgical outcomes.

Competitive position

Xtant maintains a competitive position by offering a integrated portfolio of both hardware and biologics, supported by a large network of over 670 independent distributors and significant intellectual property.

GeographiesUnited States, Europe, Canada, Mexico, South America
Customer segmentsHospitals, Integrated Delivery Networks, Group Purchasing Organizations
Business modelManufacturing, Direct Sales, Licensing
SuppliersTissue recovery agencies, Bovine collagen suppliers, Titanium and PEEK material suppliers, Contract manufacturers
CustomersIntegrated Delivery Networks (IDNs), Group Purchasing Organizations (GPOs), Hospitals, Surgical centers
Listed2007
Employees215.0
CEOSean E. Browne
FilingsSEC EDGAR

FAQ

What is Xtant Medical Holdings's market cap?
Xtant Medical Holdings (XTNT) has a market capitalization of $44.9M and trades on AMEX.
What is Xtant Medical Holdings's revenue and profitability?
Xtant Medical Holdings generated $109.5M in trailing twelve-month revenue with a net loss of $11.1M, representing a net margin of -10.2%. Gross margin stands at 59.4%, with free cash flow of -$696.0K. The latest reported period is Q2 2026.
Who are Xtant Medical Holdings's competitors?
Xtant Medical Holdings's key competitors include Orthofix Medical Inc., Globus Medical, Inc., Alphatec Holdings, Inc., and others. These companies compete in similar markets and product categories.
Who does Xtant Medical Holdings partner with?
Xtant Medical Holdings's notable partners include Vizient, Premier, HealthTrust Purchasing Group, and others.
What subsidiaries does Xtant Medical Holdings have?
Xtant Medical Holdings's subsidiaries include X-spine Systems, Inc., Xtant Medical, Inc..
Where is Xtant Medical Holdings headquartered?
Xtant Medical Holdings is headquartered in United States of America and employs approximately 215 people. It has been publicly traded since 2007.